IDXX
IDXX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
25
$108.68M
Total Volume
$108.68M
25 transactions
Net Activity
$108.68M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Mazelsky Jonathan Jay
Exec Chair of the Board
$51.51M total
Hunt Nimrata
EVP
$14.82M total
Fennell George
EVP
$11.96M total
Underberg Sharon E.
EVP, GC, Corporate Secretary
$9.68M total
Lane Michael
EVP
$8.02M total
Quick Actions
IDXX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. IDXX ranks #65 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at IDXX (IDXX) engaged in a total of 25 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 25 were sales. The total volume of insider trading reached $108.68M.
The net insider activity for IDXX shows a net selling bias of $108.68M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Mazelsky Jonathan Jay (Pres, CEO), who traded 29.3K shares valued at $18.49M on Aug 6, 2025.
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide
Illumina Stock Surges 74.8% in a Year: What's Fueling the Drive?
Idexx Labs Barks Up A Third-Quarter Beat, And Fetches Its Next Bullish Move
Idexx Stock: Pet Diagnostics Company Defies Industry Slump
IDEXX Laboratories: Great Company, But Too Expensive (Rating Downgrade)
FAQs About IDXX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for IDXX.